Certain risk factors for myocardial infarction have been linked with disturbances in fibrinolytic activity. The recent development in our laboratory of new sensitive and specific methods for determination of tissue plasminogen activator (t-PA) activity and antigen, as well as the discovery of a new rapid inhibitor of this enzyme, enabled us to study fibrinolytic function in detail in a representative population of postinfarction patients. Seventy-one patients (62 men and 9 women) who had survived a myocardial infarction before the age of 45 were compared with 50 healthy subjects of similar age, three years after the infarction. Low t-PA activity after venous occlusion, mostly explained by high plasma levels of the t-PA inhibitor and to some extent by impaired release of t-PA from the vessel wall, was a frequent finding in the patients. The level of t-PA inhibitor was positively and significantly correlated with levels of serum triglycerides. Our data suggest that reduced fibrinolytic capacity due to increased plasma levels of a rapid inhibitor of t-PA may have pathogenetic importance in myocardial infarction, particularly in patients with hypertriglyceridemia.
This article has been cited by other articles:
Bloomgarden, Z. T.
(2009). The 6th Annual World Congress on the Insulin Resistance Syndrome. Diabetes Care
32: e114-e121
[Full Text]
Pousios, D., Velissaris, T., Duggan, S., Tsang, G.
(2009). Floating intra-aortic thrombus presenting as distal arterial embolism. ICVTS
9: 532-534
[Abstract][Full Text]
Mallewa, J. E., Wilkins, E., Vilar, J., Mallewa, M., Doran, D., Back, D., Pirmohamed, M.
(2008). HIV-associated lipodystrophy: a review of underlying mechanisms and therapeutic options. J Antimicrob Chemother
62: 648-660
[Abstract][Full Text]
Bigert, C, Alderling, M, Svartengren, M, Plato, N, de Faire, U, Gustavsson, P
(2008). Blood markers of inflammation and coagulation and exposure to airborne particles in employees in the Stockholm underground. Occup. Environ. Med.
65: 655-658
[Abstract][Full Text]
Goetze, J. P.
(2008). Markers of activated coagulation in acute coronary syndromes.. J Am Coll Cardiol
51: 2430-2431
[Full Text]
Shrivastava, C. P, Devgarha, S.
(2007). Urokinase Thrombolysis in Acute-on-Chronic Vascular Occlusion of Lower Limb. Asian Cardiovasc. Thorac. Ann.
15: 405-407
[Abstract][Full Text]
Reaven, G. M.
(2007). The Individual Components of the Metabolic Syndrome: Is There a Raison d'Etre?. J. Am. Coll. Nutr.
26: 191-195
[Full Text]
Gorlatova, N. V., Cale, J. M., Elokdah, H., Li, D., Fan, K., Warnock, M., Crandall, D. L., Lawrence, D. A.
(2007). Mechanism of Inactivation of Plasminogen Activator Inhibitor-1 by a Small Molecule Inhibitor. J. Biol. Chem.
282: 9288-9296
[Abstract][Full Text]
Collet, J.P., Allali, Y., Lesty, C., Tanguy, M.L., Silvain, J., Ankri, A., Blanchet, B., Dumaine, R., Gianetti, J., Payot, L., Weisel, J.W., Montalescot, G.
(2006). Altered Fibrin Architecture Is Associated With Hypofibrinolysis and Premature Coronary Atherothrombosis. Arterioscler. Thromb. Vasc. Bio.
26: 2567-2573
[Abstract][Full Text]
Bushnell, C. D., Hurn, P., Colton, C., Miller, V. M., del Zoppo, G., Elkind, M. S.V., Stern, B., Herrington, D., Ford-Lynch, G., Gorelick, P., James, A., Brown, C. M., Choi, E., Bray, P., Newby, L. K., Goldstein, L. B., Simpkins, J.
(2006). Advancing the Study of Stroke in Women: Summary and Recommendations for Future Research From an NINDS-Sponsored Multidisciplinary Working Group. Stroke
37: 2387-2399
[Abstract][Full Text]
Kahn, S. E., Zinman, B., Haffner, S. M., O'Neill, M. C., Kravitz, B. G., Yu, D., Freed, M. I., Herman, W. H., Holman, R. R., Jones, N. P., Lachin, J. M., Viberti, G. C., the ADOPT Study Group,
(2006). Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes.. Diabetes
55: 2357-2364
[Abstract][Full Text]
Reaven, G. M
(2006). The metabolic syndrome: is this diagnosis necessary?. Am. J. Clin. Nutr.
83: 1237-1247
[Abstract][Full Text]
Festa, A., Williams, K., Tracy, R. P., Wagenknecht, L. E., Haffner, S. M.
(2006). Progression of Plasminogen Activator Inhibitor-1 and Fibrinogen Levels in Relation to Incident Type 2 Diabetes. Circulation
113: 1753-1759
[Abstract][Full Text]
Kanaya, A. M., Wassel Fyr, C., Vittinghoff, E., Harris, T. B., Park, S. W., Goodpaster, B. H., Tylavsky, F., Cummings, S. R.
(2006). Adipocytokines and incident diabetes mellitus in older adults: the independent effect of plasminogen activator inhibitor 1.. Arch Intern Med
166: 350-356
[Abstract][Full Text]
Van Gaal, L. F., Mertens, I. L., Ballaux, D.
(2005). What is the relationship between risk factor reduction and degree of weight loss?. Eur Heart J Suppl
7: L21-L26
[Abstract][Full Text]
Ross, C. J.D., Liu, G., Kuivenhoven, J. A., Twisk, J., Rip, J., van Dop, W., Ashbourne Excoffon, K. J.D., Lewis, S. M.E., Kastelein, J. J., Hayden, M. R.
(2005). Complete Rescue of Lipoprotein Lipase-Deficient Mice by Somatic Gene Transfer of the Naturally Occurring LPLS447X Beneficial Mutation. Arterioscler. Thromb. Vasc. Bio.
25: 2143-2150
[Abstract][Full Text]
Arndt, P. G., Young, S. K., Worthen, G. S.
(2005). Regulation of Lipopolysaccharide-Induced Lung Inflammation by Plasminogen Activator Inhibitor-1 through a JNK-Mediated Pathway. J. Immunol.
175: 4049-4059
[Abstract][Full Text]
Wiklund, P.-G., Nilsson, L., Ardnor, S. N., Eriksson, P., Johansson, L., Stegmayr, B., Hamsten, A., Holmberg, D., Asplund, K.
(2005). Plasminogen Activator Inhibitor-1 4G/5G Polymorphism and Risk of Stroke: Replicated Findings in Two Nested Case-Control Studies Based on Independent Cohorts. Stroke
36: 1661-1665
[Abstract][Full Text]
Yamamoto, K., Takeshita, K., Kojima, T., Takamatsu, J., Saito, H.
(2005). Aging and plasminogen activator inhibitor-1 (PAI-1) regulation: implication in the pathogenesis of thrombotic disorders in the elderly. Cardiovasc Res
66: 276-285
[Abstract][Full Text]
Lazar, H. L.
(2005). Role of Angiotensin-Converting Enzyme Inhibitors in the Coronary Artery Bypass Patient. Ann. Thorac. Surg.
79: 1081-1089
[Abstract][Full Text]
van Dielen, F. M. H., Buurman, W. A., Hadfoune, M., Nijhuis, J., Greve, J. W.
(2004). Macrophage Inhibitory Factor, Plasminogen Activator Inhibitor-1, Other Acute Phase Proteins, and Inflammatory Mediators Normalize as a Result of Weight Loss in Morbidly Obese Subjects Treated with Gastric Restrictive Surgery. J. Clin. Endocrinol. Metab.
89: 4062-4068
[Abstract][Full Text]
Betteridge, D.J.
(2004). Treating dyslipidaemia in the patient with type 2 diabetes. Eur Heart J Suppl
6: C28-C33
[Abstract][Full Text]
Ridker, P. M, Brown, N. J., Vaughan, D. E., Harrison, D. G., Mehta, J. L.
(2004). Established and Emerging Plasma Biomarkers in the Prediction of First Atherothrombotic Events. Circulation
109: IV-6-IV-19
[Full Text]
Nakamura, Y, Shimada, K, Fukuda, D, Shimada, Y, Ehara, S, Hirose, M, Kataoka, T, Kamimori, K, Shimodozono, S, Kobayashi, Y, Yoshiyama, M, Takeuchi, K, Yoshikawa, J
(2004). Implications of plasma concentrations of adiponectin in patients with coronary artery disease. Heart
90: 528-533
[Abstract][Full Text]
Zee, R. Y.L., Cook, N. R., Cheng, S., Reynolds, R., Erlich, H. A., Lindpaintner, K., Ridker, P. M.
(2004). Polymorphism in the P-selectin and interleukin-4 genes as determinants of stroke: a population-based, prospective genetic analysis. Hum Mol Genet
13: 389-396
[Abstract][Full Text]
Tsikouris, J. P., Suarez, J. A., Meyerrose, G. E., Ziska, M., Fike, D., Smith, J.
(2004). Questioning a Class Effect: Does ACE Inhibitor Tissue Penetration Influence the Degree of Fibrinolytic Balance Alteration following an Acute Myocardial Infarction?. J Clin Pharmacol
44: 150-157
[Abstract][Full Text]
Watson, K. E., Peters Harmel, A. L., Matson, G.
(2003). Atherosclerosis in Type 2 Diabetes Mellitus: The Role of Insulin Resistance. J CARDIOVASC PHARMACOL THER
8: 253-260
[Abstract]
Hoekstra, T., Geleijnse, J. M., Kluft, C., Giltay, E. J., Kok, F. J., Schouten, E. G.
(2003). 4G/4G Genotype of PAI-1 Gene Is Associated With Reduced Risk of Stroke in Elderly. Stroke
34: 2822-2828
[Abstract][Full Text]
Muller, H., Lindman, A. S., Blomfeldt, A., Seljeflot, I., Pedersen, J. I.
(2003). A Diet Rich in Coconut Oil Reduces Diurnal Postprandial Variations in Circulating Tissue Plasminogen Activator Antigen and Fasting Lipoprotein (a) Compared with a Diet Rich in Unsaturated Fat in Women. J. Nutr.
133: 3422-3427
[Abstract][Full Text]
Tracy, R. P.
(2003). Thrombin, Inflammation, and Cardiovascular Disease: An Epidemiologic Perspective. Chest
124
: 49S-57S
[Abstract][Full Text]
Holmquist, C., Larsson, S., Wolk, A., de Faire, U.
(2003). Multivitamin Supplements Are Inversely Associated with Risk of Myocardial Infarction in Men and Women--Stockholm Heart Epidemiology Program (SHEEP). J. Nutr.
133: 2650-2654
[Abstract][Full Text]
Anand, S. S., Yi, Q., Gerstein, H., Lonn, E., Jacobs, R., Vuksan, V., Teo, K., Davis, B., Montague, P., Yusuf, S.
(2003). Relationship of Metabolic Syndrome and Fibrinolytic Dysfunction to Cardiovascular Disease. Circulation
108: 420-425
[Abstract][Full Text]
Fadl, Y. Y., Zareba, W., Moss, A. J., Marder, V. J., Sparks, C. S., Miller Watelet, L. F., Carroll, E. R.
(2003). History of Hypertension and Enhanced Thrombogenic Activity in Postinfarction Patients. Hypertension
41: 943-949
[Abstract][Full Text]
Atherosclerosis, Thrombosis, and Vascular Biology,
(2003). No Evidence of Association Between Prothrombotic Gene Polymorphisms and the Development of Acute Myocardial Infarction at a Young Age. Circulation
107: 1117-1122
[Abstract][Full Text]
Chia, S., Ludlam, C. A., Fox, K. A. A., Newby, D. E.
(2003). Acute systemic inflammation enhances endothelium-dependent tissue plasminogen activator release in men. J Am Coll Cardiol
41: 333-339
[Abstract][Full Text]
RuDusky, B. M., Lohin, D. L.
(2003). Acute Myocardial Infarction in a 16-Year-Old Male: A Case Report. ANGIOLOGY
54: 103-107
[Abstract]
Ikezaki, A., Hosoda, H., Ito, K., Iwama, S., Miura, N., Matsuoka, H., Kondo, C., Kojima, M., Kangawa, K., Sugihara, S.
(2002). Fasting Plasma Ghrelin Levels Are Negatively Correlated With Insulin Resistance and PAI-1, but Not With Leptin, in Obese Children and Adolescents. Diabetes
51: 3408-3411
[Abstract][Full Text]
Ruberg, F. L, Loscalzo, J.
(2002). Prothrombotic determinants of coronary atherothrombosis. Vasc Med
7: 289-299
[Abstract]
Yamamoto, K., Shimokawa, T., Yi, H., Isobe, K.-i., Kojima, T., Loskutoff, D. J., Saito, H.
(2002). Aging Accelerates Endotoxin-Induced Thrombosis : Increased Responses of Plasminogen Activator Inhibitor-1 and Lipopolysaccharide Signaling with Aging. Am. J. Pathol.
161: 1805-1814
[Abstract][Full Text]
RuDusky, B. M., Akosan, K. O.
(2002). Myocardial Infarction in the Very Young. Chest
122: 1099-1100
[Full Text]
Chavakis, T., Pixley, R. A., Isordia-Salas, I., Colman, R. W., Preissner, K. T.
(2002). A Novel Antithrombotic Role for High Molecular Weight Kininogen as Inhibitor of Plasminogen Activator Inhibitor-1 Function. J. Biol. Chem.
277: 32677-32682
[Abstract][Full Text]
Eren, M., Painter, C. A., Atkinson, J. B., Declerck, P. J., Vaughan, D. E.
(2002). Age-Dependent Spontaneous Coronary Arterial Thrombosis in Transgenic Mice That Express a Stable Form of Human Plasminogen Activator Inhibitor-1. Circulation
106: 491-496
[Abstract][Full Text]
Salobir, B., Sabovic, M., Peternel, P., Stegnar, M.
(2002). Fibrinolytic Parameters and Lipoprotein(a) in Young Women with Myocardial Infarction. ANGIOLOGY
53: 157-163
[Abstract]
Hori, Y., Gabazza, E. C., Yano, Y., Katsuki, A., Suzuki, K., Adachi, Y., Sumida, Y.
(2002). Insulin Resistance Is Associated with Increased Circulating Level of Thrombin-Activatable Fibrinolysis Inhibitor in Type 2 Diabetic Patients. J. Clin. Endocrinol. Metab.
87: 660-665
[Abstract][Full Text]
Newby, D E, Witherow, F N, Wright, R A, Bloomfield, P, Ludlam, C A, Boon, N A, Fox, K A A, Webb, D J
(2002). Hypercholesterolaemia and lipid lowering treatment do not affect the acute endogenous fibrinolytic capacity in vivo. Heart
87: 48-53
[Abstract][Full Text]
Herrington, D. M., Klein, K. P.
(2001). Genome and Hormones: Gender Differences in Physiology: Invited Review: Pharmacogenetics of estrogen replacement therapy. J. Appl. Physiol.
91: 2776-2784
[Abstract][Full Text]
Muller, A. F., Leebeek, F. W. G., Janssen, J. A. M. J. L., Lamberts, S. W. J., Hofland, L., van der Lely, A. J.
(2001). Acute Effect of Pegvisomant on Cardiovascular Risk Markers in Healthy Men: Implications for the Pathogenesis of Atherosclerosis in GH Deficiency. J. Clin. Endocrinol. Metab.
86: 5165-5171
[Abstract][Full Text]
Landin-Wilhelmsen, K., Bryman, I., Wilhelmsen, L.
(2001). Cardiac Malformations and Hypertension, But Not Metabolic Risk Factors, Are Common in Turner Syndrome. J. Clin. Endocrinol. Metab.
86: 4166-4170
[Abstract][Full Text]
Pandolfi, A., Cetrullo, D., Polishuck, R., Alberta, M. M., Calafiore, A., Pellegrini, G., Vitacolonna, E., Capani, F., Consoli, A.
(2001). Plasminogen Activator Inhibitor Type 1 Is Increased in the Arterial Wall of Type II Diabetic Subjects. Arterioscler. Thromb. Vasc. Bio.
21: 1378-1382
[Abstract][Full Text]
Zhu, Y., Farrehi, P. M., Fay, W. P.
(2001). Plasminogen Activator Inhibitor Type 1 Enhances Neointima Formation After Oxidative Vascular Injury in Atherosclerosis-Prone Mice. Circulation
103: 3105-3110
[Abstract][Full Text]
Brown, N. J., Murphey, L. J., Srikuma, N., Koschachuhanan, N., Williams, G. H., Vaughan, D. E.
(2001). Interactive Effect of PAI-1 4G/5G Genotype and Salt Intake on PAI-1 Antigen. Arterioscler. Thromb. Vasc. Bio.
21: 1071-1077
[Abstract][Full Text]
Williams, M. S., Bray, P. F.
(2001). Genetics of Arterial Prothrombotic Risk States. Exp. Biol. Med.
226: 409-419
[Abstract][Full Text]
Newby, D. E., McLeod, A. L., Uren, N. G., Flint, L., Ludlam, C. A., Webb, D. J., Fox, K. A. A., Boon, N. A.
(2001). Impaired Coronary Tissue Plasminogen Activator Release Is Associated With Coronary Atherosclerosis and Cigarette Smoking : Direct Link Between Endothelial Dysfunction and Atherothrombosis. Circulation
103: 1936-1941
[Abstract][Full Text]
De Lorenzo, F., Noorani, A., Kakkar, V.V.
(2001). Current trends in the management of thromboembolic events. QJM
94: 179-185
[Full Text]
Jeppesen, J., Hein, H. O., Suadicani, P., Gyntelberg, F.
(2001). Low Triglycerides-High High-Density Lipoprotein Cholesterol and Risk of Ischemic Heart Disease. Arch Intern Med
161: 361-366
[Abstract][Full Text]
Eitzman, D. T., Westrick, R. J., Xu, Z., Tyson, J., Ginsburg, D.
(2000). Plasminogen activator inhibitor-1 deficiency protects against atherosclerosis progression in the mouse carotid artery. Blood
96: 4212-4215
[Abstract][Full Text]
Knowles, J. W., Maeda, N.
(2000). Genetic Modifiers of Atherosclerosis in Mice. Arterioscler. Thromb. Vasc. Bio.
20: 2336-2345
[Abstract][Full Text]
Felmeden, D. C, Lip, G. Y.
(2000). The renin-angiotensin-aldosterone system and fibrinolysis. Journal of Renin-Angiotensin-Aldosterone System
1: 240-244
Bounameaux, H., Kruithof, E. K. O.
(2000). On the Association of Elevated tPA/PAI-1 Complex and von Willebrand Factor With Recurrent Myocardial Infarction. Arterioscler. Thromb. Vasc. Bio.
20: 1857-1859
[Full Text]
Wiman, B., Andersson, T., Hallqvist, J., Reuterwall, C., Ahlbom, A., deFaire, U.
(2000). Plasma Levels of Tissue Plasminogen Activator/Plasminogen Activator Inhibitor-1 Complex and von Willebrand Factor Are Significant Risk Markers for Recurrent Myocardial Infarction in the Stockholm Heart Epidemiology Program (SHEEP) Study. Arterioscler. Thromb. Vasc. Bio.
20: 2019-2023
[Abstract][Full Text]
Jeppesen, J., Hein, H. O., Suadicani, P., Gyntelberg, F.
(2000). High Triglycerides and Low HDL Cholesterol and Blood Pressure and Risk of Ischemic Heart Disease. Hypertension
36: 226-232
[Abstract][Full Text]
Kohler, H. P., Grant, P. J.
(2000). Plasminogen-Activator Inhibitor Type 1 and Coronary Artery Disease. NEJM
342: 1792-1801
[Full Text]
Tabengwa, E. M., Benza, R. L., Grenett, H. E., Booyse, F. M.
(2000). Hypertriglyceridemic VLDL Downregulates Tissue Plasminogen Activator Gene Transcription Through cis-Repressive Region(s) in the Tissue Plasminogen Activator Promoter in Cultured Human Endothelial Cells. Arterioscler. Thromb. Vasc. Bio.
20: 1675-1681
[Abstract][Full Text]
Teede, H. J., McGrath, B. P., Smolich, J. J., Malan, E., Kotsopoulos, D., Liang, Y.-L., Peverill, R. E.
(2000). Postmenopausal Hormone Replacement Therapy Increases Coagulation Activity and Fibrinolysis. Arterioscler. Thromb. Vasc. Bio.
20: 1404-1409
[Abstract][Full Text]
Sjoland, H., Eitzman, D. T., Gordon, D., Westrick, R., Nabel, E. G., Ginsburg, D.
(2000). Atherosclerosis Progression in LDL Receptor-Deficient and Apolipoprotein E-Deficient Mice Is Independent of Genetic Alterations in Plasminogen Activator Inhibitor-1. Arterioscler. Thromb. Vasc. Bio.
20: 846-852
[Abstract][Full Text]
Eitzman, D. T., Westrick, R. J., Nabel, E. G., Ginsburg, D.
(2000). Plasminogen activator inhibitor-1 and vitronectin promote vascular thrombosis in mice. Blood
95: 577-580
[Abstract][Full Text]
Brown, N. J., Kim, K.-S., Chen, Y.-Q., Blevins, L. S., Nadeau, J. H., Meranze, S. G., Vaughan, D. E.
(2000). Synergistic Effect of Adrenal Steroids and Angiotensin II on Plasminogen Activator Inhibitor-1 Production. J. Clin. Endocrinol. Metab.
85: 336-344
[Abstract][Full Text]
Bavry, A. A., Li, D., Zander, D. S., Phillips, M. I., Mehta, J. L.
(2000). Inhibition of Arterial Thrombogenesis by Quinapril but Not Losartan. J CARDIOVASC PHARMACOL THER
5: 121-127
[Abstract]
Nordoy, A., Bonaa, K. H., Sandset, P. M., Hansen, J.-B., Nilsen, H.
(2000). Effect of {omega}-3 Fatty Acids and Simvastatin on Hemostatic Risk Factors and Postprandial Hyperlipemia in Patients With Combined Hyperlipemia. Arterioscler. Thromb. Vasc. Bio.
20: 259-265
[Abstract][Full Text]
Jager, A., van Hinsbergh, V. W. M., Kostense, P. J., Emeis, J. J., Yudkin, J. S., Nijpels, G., Dekker, J. M., Heine, R. J., Bouter, L. M., Stehouwer, C. D. A.
(1999). von Willebrand Factor, C-Reactive Protein, and 5-Year Mortality in Diabetic and Nondiabetic Subjects : The Hoorn Study. Arterioscler. Thromb. Vasc. Bio.
19: 3071-3078
[Abstract][Full Text]
Abbasi, F., McLaughlin, T., Lamendola, C., Lipinska, I., Tofler, G., Reaven, G. M.
(1999). Comparison of Plasminogen Activator Inhibitor-1 Concentration in Insulin-Resistant Versus Insulin-Sensitive Healthy Women. Arterioscler. Thromb. Vasc. Bio.
19: 2818-2821
[Abstract][Full Text]
Tataru, M.-C., Heinrich, J., Junker, R., Schulte, H., von Eckardstein, A., Assmann, G., Koehler, E.
(1999). D-dimers in relation to the severity of arteriosclerosis in patients with stable angina pectoris after myocardial infarction. Eur Heart J
20: 1493-1502
[Abstract]
Nauck, M., Wieland, H., Marz, W.
(1999). Rapid, Homogeneous Genotyping of the 4G/5G Polymorphism in the Promoter Region of the PAI1 Gene by Fluorescence Resonance Energy Transfer and Probe Melting Curves. Clin. Chem.
45: 1141-1147
[Abstract][Full Text]
Brown, N. J., Agirbasli, M., Vaughan, D. E.
(1999). Comparative Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Type 1 Receptor Antagonism on Plasma Fibrinolytic Balance in Humans. Hypertension
34: 285-290
[Abstract][Full Text]
Banfi, C., Mussoni, L., Rise, P., Cattaneo, M. G., Vicentini, L., Battaini, F., Galli, C., Tremoli, E.
(1999). Very Low Density Lipoprotein–Mediated Signal Transduction and Plasminogen Activator Inhibitor Type 1 in Cultured HepG2 Cells. Circ. Res.
85: 208-217
[Abstract][Full Text]
Zidovetzki, R., Wang, J.-L., Kim, J. A., Chen, P., Fisher, M., Hofman, F. M.
(1999). Endothelin-1 Enhances Plasminogen Activator Inhibitor-1 Production by Human Brain Endothelial Cells via Protein Kinase C-Dependent Pathway. Arterioscler. Thromb. Vasc. Bio.
19: 1768-1775
[Abstract][Full Text]
Tracy, R. P., Arnold, A. M., Ettinger, W., Fried, L., Meilahn, E., Savage, P.
(1999). The Relationship of Fibrinogen and Factors VII and VIII to Incident Cardiovascular Disease and Death in the Elderly : Results From the Cardiovascular Health Study. Arterioscler. Thromb. Vasc. Bio.
19: 1776-1783
[Abstract][Full Text]
Ardissino, D., Mannucci, P.M., Merlini, P.A., Duca, F., Fetiveau, R., Tagliabue, L., Tubaro, M., Galvani, M., Ottani, F., Ferrario, M., Corral, J., Margaglione, M.
(1999). Prothrombotic Genetic Risk Factors in Young Survivors of Myocardial Infarction. Blood
94: 46-51
[Abstract][Full Text]
Goodfield, N. E. R., Newby, D. E., Ludlam, C. A., Flapan, A. D.
(1999). Effects of Acute Angiotensin II Type 1 Receptor Antagonism and Angiotensin Converting Enzyme Inhibition on Plasma Fibrinolytic Parameters in Patients With Heart Failure. Circulation
99: 2983-2985
[Abstract][Full Text]
Cesari, M., Rossi, G. P.
(1999). Plasminogen Activator Inhibitor Type 1 in Ischemic Cardiomyopathy. Arterioscler. Thromb. Vasc. Bio.
19: 1378-1386
[Full Text]
Sobel, B. E.
(1999). Increased Plasminogen Activator Inhibitor-1 and Vasculopathy : A Reconcilable Paradox. Circulation
99: 2496-2498
[Full Text]
Nilsson, L., Gåfvels, M., Musakka, L., Ensler, K., Strickland, D. K., Angelin, B., Hamsten, A., Eriksson, P.
(1999). VLDL activation of plasminogen activator inhibitor-1 (PAI-1) expression: involvement of the VLDL receptor. J. Lipid Res.
40: 913-919
[Abstract][Full Text]
Allison, B. A., Nilsson, L., Karpe, F., Hamsten, A., Eriksson, P.
(1999). Effects of Native, Triglyceride-Enriched, and Oxidatively Modified LDL on Plasminogen Activator Inhibitor-1 Expression in Human Endothelial Cells. Arterioscler. Thromb. Vasc. Bio.
19: 1354-1360
[Abstract][Full Text]
Brunner-La Rocca, H. P., Vaddadi, G., Esler, M. D.
(1999). Recent insight into therapy of congestive heart failure: focus on ACE inhibition and angiotensin-II antagonism. J Am Coll Cardiol
33: 1163-1173
[Abstract][Full Text]
Newby, D. E., Wright, R. A., Labinjoh, C., Ludlam, C. A., Fox, K. A. A., Boon, N. A., Webb, D. J.
(1999). Endothelial Dysfunction, Impaired Endogenous Fibrinolysis, and Cigarette Smoking : A Mechanism for Arterial Thrombosis and Myocardial Infarction. Circulation
99: 1411-1415
[Abstract][Full Text]
Festa, A., D'Agostino, R. Jr, Mykkanen, L., Tracy, R., Howard, B. V., Haffner, S. M.
(1999). Low-Density Lipoprotein Particle Size Is Inversely Related to Plasminogen Activator Inhibitor-1 Levels : The Insulin Resistance Atherosclerosis Study. Arterioscler. Thromb. Vasc. Bio.
19: 605-610
[Abstract][Full Text]
Zidovetzki, R., Chen, P., Fisher, M., Hofman, F. M., Faraci, F. M.
(1999). Nicotine Increases Plasminogen Activator Inhibitor-1 Production by Human Brain Endothelial Cells via Protein Kinase C–Associated Pathway • Editorial Comment. Stroke
30: 651-655
[Abstract][Full Text]
Cesari, M., Sartori, M. T., Patrassi, G. M., Vettore, S., Rossi, G. P.
(1999). Determinants of Plasma Levels of Plasminogen Activator Inhibitor-1 : A Study of Normotensive Twins. Arterioscler. Thromb. Vasc. Bio.
19: 316-320
[Abstract][Full Text]
Andrews, T. C., Parker, J. D., Jacobs, S., Friedman, R., Cummings, N., MacCallum, G., Mannting, F., Tofler, G. H., Carlson, W., Muller, J. E., Stone, P. H.
(1998). Effects of therapy with nifedipine GITS or atenolol on mental stress-induced ischemic left ventricular dysfunction. J Am Coll Cardiol
32: 1680-1686
[Abstract][Full Text]
Nilsson, L., Banfi, C., Diczfalusy, U., Tremoli, E., Hamsten, A., Eriksson, P.
(1998). Unsaturated Fatty Acids Increase Plasminogen Activator Inhibitor-1 Expression in Endothelial Cells. Arterioscler. Thromb. Vasc. Bio.
18: 1679-1685
[Abstract][Full Text]
Grenett, H. E., Benza, R. L., Fless, G. M., Li, X.-N., Davis, G. C., Booyse, F. M.
(1998). Genotype-Specific Transcriptional Regulation of PAI-1 Gene by Insulin, Hypertriglyceridemic VLDL, and Lp(a) in Transfected, Cultured Human Endothelial Cells. Arterioscler. Thromb. Vasc. Bio.
18: 1803-1809
[Abstract][Full Text]
Jansson, J-H, Nilsson, T K, Johnson, O
(1998). von Willebrand factor, tissue plasminogen activator, and dehydroepiandrosterone sulphate predict cardiovascular death in a 10 year follow up of survivors of acute myocardial infarction. Heart
80: 334-337
[Abstract][Full Text]
Geppert, A., Graf, S., Beckmann, R., Hornykewycz, S., Schuster, E., Binder, B. R., Huber, K.
(1998). Concentration of Endogenous tPA Antigen in Coronary Artery Disease : Relation to Thrombotic Events, Aspirin Treatment, Hyperlipidemia, and Multivessel Disease. Arterioscler. Thromb. Vasc. Bio.
18: 1634-1642
[Abstract][Full Text]
Sowers, J. R.
(1998). Obesity and cardiovascular disease. Clin. Chem.
44: 1821-1825
[Abstract][Full Text]
Rosenson, R. S., Tangney, C. C.
(1998). Antiatherothrombotic Properties of Statins: Implications for Cardiovascular Event Reduction. JAMA
279: 1643-1650
[Abstract][Full Text]
Newby, D. E, Wright, R. A, Dawson, P., Ludlam, C. A, Boon, N. A, Fox, K. A.A, Webb, D. J
(1998). The L-arginine/nitric oxide pathway contributes to the acute release of tissue plasminogen activator in vivo in man. Cardiovasc Res
38: 485-492
[Abstract][Full Text]
Sonmez, H., Suer, S., Ulutin, T., Kokoglu, E., Ucisik, N.
(1998). The Relationship of Various Factors in the Pathogenesis of Atherosclerosis. CLIN APPL THROMB HEMOST
4: 105-110
[Abstract]
Jeppesen, J o., Hein, H. O., Suadicani, P., Gyntelberg, F.
(1998). Triglyceride Concentration and Ischemic Heart Disease : An Eight-Year Follow-up in the Copenhagen Male Study. Circulation
97: 1029-1036
[Abstract][Full Text]
Genser, N., Lechleitner, P., Maier, J., Dienstl, F., Artner-Dworzak, E., Puschendorf, B., Mair, J.
(1998). Rebound increase of plasminogen activator inhibitor type 1 after cessation of thrombolytic treatment for acute myocardial infarction is independent of type of plasminogen activator used. Clin. Chem.
44: 209-214
[Abstract][Full Text]
